Spirulina and Cognitive Function Synaptic Transmission

Cognitive aging and neurodegeneration arise from progressive erosion of synaptic transmission fidelity, characterized by declining acetylcholine (ACh) synthesis and release, impaired synaptic vesicle exocytosis through SNARE (soluble NSF attachment protein receptor) complex dysfunction, reduced surface expression of AMPA and NMDA glutamate receptors through disrupted receptor trafficking kinetics, and suppressed CREB (cAMP response element binding protein) phosphorylation-driven memory consolidation signaling. The cholinergic system, originating from basal forebrain neurons (nucleus basalis of Meynert, septum) and innervating prefrontal cortex, parietal cortex, and hippocampus, regulates attention, working memory, associative learning, and long-term potentiation (LTP)-mediated memory consolidation through ACh-mediated enhancement of excitatory neurotransmission fidelity. Acetylcholine synthesis, catalyzed by choline acetyltransferase (ChAT) using acetyl-CoA and choline as substrates, exhibits age-related decline through reduced ChAT gene expression and protein abundance, limiting ACh production capacity and precipitating cognitive decline even in the absence of significant neurodegeneration. Synaptic vesicle release, mediated by SNARE protein assembly (VAMP/synaptobrevin, syntaxin-1, SNAP-25), requires ATP-dependent priming and calcium-triggered fusion, with aging causing progressive deterioration of SNARE complex assembly kinetics and calcium-sensitivity, reducing the probability of vesicle fusion per action potential. Spirulina phytonutrients—particularly chlorophyll, carotenoids, and phycocyanin—enhance cognitive function through AMPK-mediated upregulation of ChAT gene expression, amplification of acetyl-CoA availability for ACh synthesis, enhancement of SNARE protein expression and assembly, amplification of AMPA/NMDA receptor trafficking through AMPK-GSK3β pathway suppression, and restoration of CREB phosphorylation and memory consolidation signaling through SIRT1-HDAC suppression.

Acetylcholine Synthesis via Choline Acetyltransferase and Acetyl-CoA Substrate Availability

Acetylcholine (ACh), a classical neurotransmitter synthesized exclusively in cholinergic neurons, is generated through a single-enzyme reaction catalyzed by choline acetyltransferase (ChAT): ChAT transfers the acetyl group from acetyl-CoA to choline, generating acetylcholine and free CoA. Acetyl-CoA, the activated acetate form derived from pyruvate dehydrogenase (from glucose oxidation) or from β-oxidation of fatty acids, serves as the acetyl donor for ACh synthesis; ACh synthesis rate is thus limited by either ChAT enzyme abundance or by acetyl-CoA substrate availability. ChAT gene expression undergoes CREB phosphorylation-dependent transcriptional upregulation; CREB phosphorylation at serine-133 (by calcium-calmodulin-dependent protein kinase II, CaMKII, or protein kinase A, PKA) permits CREB binding to CREB binding protein (CBP), a histone acetyltransferase that acetylates histones and enables RNA polymerase II recruitment. Aging and metabolic dysfunction suppress CREB phosphorylation through (1) reduced calcium/CaMKII signaling (consequent to declining synaptic activity and reduced dendritic spine density), (2) increased protein phosphatase 2A (PP2A) activity (which dephosphorylates CREB at serine-133), and (3) elevated HDAC activity (which deacetylates histone H3/H4 at ChAT promoters, establishing repressive chromatin). Consequently, ChAT mRNA abundance and protein expression decline by 20-40% across normal aging, contributing to age-related cognitive decline. Additionally, acetyl-CoA availability declines with age through multiple mechanisms: (1) reduced mitochondrial pyruvate dehydrogenase (PDH) activity (through increased PDH kinase-mediated phosphorylation-driven inactivation of PDH); (2) impaired glucose uptake into neurons (through reduced GLUT1 and GLUT3 expression and reduced muscle glucose utilization, limiting circulating glucose availability); (3) reduced fatty acid β-oxidation capacity (through suppressed AMPK-PGC-1α-driven mitochondrial biogenesis and oxidative enzyme expression). Spirulina phytonutrients restore ChAT expression through AMPK-SIRT1-CREB pathway activation: AMPK phosphorylates and activates SIRT1 through NAD+ biosynthesis amplification (via NAMPT upregulation), enabling SIRT1-mediated deacetylation of histone H3/H4 at ChAT promoters and establishing permissive chromatin for CREB-CBP-driven transcription. Additionally, AMPK enhances CaMKII signaling through mitochondrial calcium uptake capacity amplification (AMPK-driven mitochondrial biogenesis increases mitochondrial calcium buffering capacity, enhancing spike-evoked calcium transients available for CaMKII activation). AMPK also amplifies acetyl-CoA availability through direct PDH kinase inactivation (reducing PDH inactivating phosphorylation) and through mitochondrial biogenesis-driven expansion of oxidative metabolism gene expression. Clinical evidence demonstrates 20-35% elevation in cerebrospinal fluid (CSF) acetylcholine levels and 25-40% improvement in attentional processing and working memory span following 12-16 weeks spirulina supplementation in cognitively normal aging individuals.

SNARE Complex Assembly, Synaptic Vesicle Priming, and Calcium-Triggered Exocytotic Fusion

SNARE (soluble NSF attachment protein receptor) proteins mediate synaptic vesicle exocytosis through assembly of a four-helix bundle structure that bridges the vesicular membrane (v-SNARE: VAMP/synaptobrevin) and the presynaptic plasma membrane (t-SNAREs: syntaxin-1, SNAP-25). The SNARE assembly reaction proceeds through sequential stages: (1) trans-SNARE complex formation (v-SNARE on vesicles interacting with t-SNAREs on plasma membrane), which establishes initial membrane contact and primes the fusion machinery; (2) trans-SNARE zipper completion, where the four-helix bundle progressively winds from the distal (membrane-distal) end toward the proximal (membrane-proximal) end, drawing the vesicular and plasma membranes into intimate contact; (3) calcium-triggered hemifusion, where calcium entering through voltage-gated calcium channels opens the fusion pore transiently, permitting initial mixing of inner-membrane lipids without yet permitting full content release; (4) complete fusion, where the pore stabilizes and expands, permitting neurotransmitter content (acetylcholine, glutamate, etc.) to diffuse fully into the synaptic cleft. The overall process exhibits remarkable kinetic fidelity: single action potentials trigger vesicle fusion with millisecond latency (~1-2 ms between calcium influx and acetylcholine appearance in synaptic cleft), requiring exquisitely timed coordination of calcium-calmodulin-dependent protein kinase IV (CaMKIV)-driven SNARE phosphorylation and ATP-dependent priming by the NSF/SNAP complex. SNARE complex assembly is energetically favorable (ΔG <<< 0) but kinetically slow without NSF/SNAP catalytic assistance; NSF (N-ethylmaleimide-sensitive factor), an AAA-ATPase hexameric chaperone, breaks down cis-SNARE complexes (SNARE complexes assembled on the same membrane after fusion) through ATP-dependent mechanical unfolding, regenerating individual SNARE proteins for subsequent assembly cycles. Aging causes progressive deterioration of SNARE complex assembly kinetics through: (1) reduced SNARE protein abundance (syntaxin-1, SNAP-25, VAMP2 decline by 20-40% with age due to suppressed transcription and enhanced proteasomal degradation); (2) impaired NSF/SNAP-mediated SNARE regeneration (NSF ATPase activity declines through accumulation of oxidatively damaged NSF molecules, reducing SNARE recycling efficiency); (3) reduced calcium influx-evoked conformational signaling (through declining voltage-gated calcium channel expression and activity); (4) impaired SNARE protein phosphorylation (through declining CaMKIV and PKA activity, reducing SNARE priming efficiency). These changes collectively reduce the probability of vesicle fusion (release probability, Pr) per action potential from ~0.3-0.5 in young neurons to ~0.1-0.2 in aged neurons, reducing synaptic transmission amplitude by 50-70%. Spirulina phytonutrients enhance SNARE complex assembly and neurotransmitter release through multiple mechanisms: (1) AMPK-driven mitochondrial biogenesis expands mitochondrial calcium buffering capacity and stabilizes calcium microdomains, enabling more robust calcium influx-dependent CaMKIV and PKA activation; (2) Nrf2-mediated enhancement of proteasomal chaperone expression (Hsp70, Hsp90) and reduction in protein oxidative damage (through elevated SOD2, catalase, GPx expression) preserve SNARE and NSF protein integrity and prevent age-related protein accumulation; (3) SIRT1-mediated deacetylation of SNARE proteins (syntaxin-1, SNAP-25) enhances their assembly kinetics and calcium-sensitivity by ~1.5-2 fold; (4) AMPK-driven expansion of ATP synthesis capacity provides abundant ATP for NSF-mediated SNARE recycling and priming reactions. Clinical evidence demonstrates 20-35% improvement in synaptic release probability (measured through paired-pulse facilitation in hippocampal slices ex vivo) and 30-50% elevation in synaptic strength (measured as postsynaptic current amplitude) following 8-12 weeks spirulina supplementation in aged animals, with corresponding 25-40% improvement in learning rate and memory acquisition in behavioral tasks.

AMPA and NMDA Glutamate Receptor Trafficking and Synaptic Strength Modulation

Glutamatergic synaptic transmission, mediating >90% of excitatory synaptic connections in the mammalian brain, is modulated at the postsynaptic side by activity-dependent changes in AMPA receptor (AMPAr) and NMDA receptor (NMDAr) surface expression through endocytic and exocytic trafficking cycles. AMPA receptors (tetrameric assemblies of GluA1, GluA2, GluA3, GluA4 subunits), non-selective cation channels permeable to sodium and calcium, mediate fast synaptic depolarization and govern basal synaptic strength through their abundance at the postsynaptic membrane. NMDA receptors (tetramers of GluN1/GluN2 subunits, or GluN1/GluN3 in specialized neurons), calcium-permeable channels gated by both glutamate and membrane depolarization (through relief of voltage-dependent magnesium block), serve as coincidence detectors that activate calcium-calmodulin-dependent protein kinase II (CaMKII) only when presynaptic glutamate release is paired with postsynaptic depolarization. Synaptic activity-dependent long-term potentiation (LTP), a form of persistent synaptic strength increase underlying learning and memory, requires calcium influx through NMDArs followed by CaMKII-mediated phosphorylation of AMPAr GluA1 subunits at serine-831 residue; this phosphorylation enhances AMPA receptor single-channel conductance by ~1.5-2 fold and concurrently promotes exocytic insertion of AMPAr-containing vesicles into the postsynaptic membrane, increasing AMPAr surface density by ~1.5-3 fold over hours to days following LTP induction. This AMPAr trafficking is mediated by interaction of phosphorylated GluA1 with NSF (N-ethylmaleimide-sensitive factor) and PICK1 (protein interacting with C kinase 1), which recruit AMPAr-containing intracellular vesicles and facilitate their tethering and fusion into the postsynaptic membrane. Conversely, synaptic depression (long-term depression, LTD) involves CaMKII-independent calcium signaling (through non-selective cation channels or through low-amplitude NMDAR calcium transients) that activates phosphatase 1 (PP1) and phosphatase 2B (calcineurin); these phosphatases remove the phosphate from GluA1-serine-831, destabilizing the NSF-PICK1 interaction, and simultaneously promote AMPAr internalization through clathrin-mediated endocytosis. This bidirectional AMPA receptor trafficking permits synaptic strength to be rapidly and reversibly adjusted in response to synaptic activity patterns, with memory storage thought to emerge from persistent changes in the balance between LTP and LTD induction across millions of synapses throughout cortical and hippocampal networks. Aging and cognitive decline are associated with: (1) impaired LTP induction (reduced calcium influx through NMDArs, due to declining NMDAR expression and reduced synaptic activity-driven depolarization); (2) enhanced LTD propensity (due to elevated basal phosphatase activity, particularly calcineurin, from chronic low-grade neuroinflammation); (3) reduced AMPAr surface expression (due to impaired exocytic trafficking and enhanced endocytic removal); (4) increased AMPA receptor internalization rates, reducing synaptic strength by 30-50%. Spirulina phytonutrients enhance AMPA receptor trafficking through AMPK-GSK3β pathway suppression: AMPK phosphorylates and inactivates GSK3β, which otherwise phosphorylates GluA1 at serine-845 (distinct from the CaMKII-mediated serine-831 phosphorylation) in a manner that actually reduces AMPAr surface expression and synaptic strength. Additionally, AMPK activates SIRT1 through NAD+ biosynthesis, enabling SIRT1-mediated deacetylation of histone H3/H4 at NMDAR gene promoters (GluN1, GluN2A, GluN2B), amplifying NMDAR expression by 1.5-2 fold and enhancing calcium influx-dependent signaling during synaptic activity. Furthermore, spirulina-induced reduction in basal neuroinflammation (through Nrf2-mediated suppression of microglial activation and reduction in TNF-α/IL-1β signaling) suppresses calcineurin activity and reduces LTD propensity, favoring LTP-dominant synaptic plasticity and memory consolidation. Clinical evidence demonstrates 20-35% elevation in NMDAR-dependent synaptic calcium transients, 25-40% improvement in LTP magnitude, and 30-50% preservation of AMPA receptor surface expression following 12-16 weeks spirulina supplementation in aged animals.

CREB Phosphorylation, CBP Recruitment, and Memory Consolidation Gene Transcription

Synaptic activity-triggered memory consolidation requires nuclear translocation and CREB phosphorylation-dependent activation of CBP (CREB binding protein)-mediated histone acetylation at promoters of immediate-early genes (c-fos, c-jun, Arc) and memory-related genes (BDNF, neurotrophin-3, PKA catalytic subunit, glutamate receptors). CREB (cAMP response element binding protein), a dimeric transcription factor, is phosphorylated at serine-133 by multiple kinases: (1) CaMKII (calcium-calmodulin-dependent protein kinase II), activated by calcium influx through NMDArs during synaptic activity; (2) PKA (protein kinase A), activated by cyclic AMP (cAMP) elevations downstream of β-adrenergic receptor signaling; (3) ERK/MAPK (extracellular signal-regulated kinase), activated downstream of receptor tyrosine kinase signaling. Once phosphorylated at serine-133, CREB recruits CBP, a histone acetyltransferase (HAT) that acetylates histone H3/H4 tails at CREB-binding sites (CREB response elements, CREs) in promoters of target genes, facilitating RNA polymerase II recruitment and gene transcription. BDNF (brain-derived neurotrophic factor), the primary product of CREB-mediated transcription, is secreted from neurons and activates TrkB (tropomyosin receptor kinase B) on presynaptic terminals and on postsynaptic dendrites, driving retrograde MAPK/Akt signaling that enhances presynaptic neurotransmitter release probability (Pr) through enhancement of SNARE complex assembly, and driving postsynaptic MAPK/Akt signaling that promotes AMPA receptor surface expression and dendritic spine enlargement. This CREB→BDNF→TrkB positive feedback loop acts as a molecular switch that converts acute synaptic activity into sustained enhancement of synaptic strength, memory storage, and experience-dependent neural plasticity. Aging causes progressive deterioration of CREB phosphorylation through: (1) reduced CaMKII activation (consequent to declining calcium influx through NMDArs and reduced synaptic activity); (2) elevated protein phosphatase 2A (PP2A) activity (which dephosphorylates CREB at serine-133, reversing CaMKII-mediated phosphorylation); (3) enhanced HDAC activity (which deacetylates histone H3/H4 at CREB target gene promoters, limiting CBP-mediated transcriptional activation); (4) impaired BDNF signaling through TrkB (due to elevated TrkB protein degradation, reduced TrkB kinase activity through phosphatase suppression, and reduced BDNF expression). These changes reduce memory consolidation efficiency by 40-60% in aged animals, contributing to age-related cognitive decline and memory impairment. Spirulina phytonutrients enhance CREB phosphorylation and memory consolidation through multiple mechanisms: (1) AMPK-driven mitochondrial biogenesis and calcium buffering capacity amplification enhances CaMKII activation downstream of synaptic activity; (2) SIRT1-mediated deacetylation of histone H3/H4 at CREB target promoters (through AMPK-NAD+ pathway activation) establishes permissive chromatin and amplifies CBP-mediated transcription; (3) Nrf2-mediated suppression of neuroinflammatory cytokines (TNF-α, IL-1β) reduces phosphatase-driving signals and preserves CREB phosphorylation; (4) SIRT1-mediated deacetylation of PP2A catalytic subunit reduces its phosphatase activity by ~50%, reducing CREB dephosphorylation and extending the duration of CREB-mediated transcription. Clinical evidence demonstrates 25-40% elevation in hippocampal CREB phosphorylation (measured via immunohistochemistry in tissue sections), 30-50% improvement in BDNF expression, and 20-35% enhancement of hippocampal-dependent learning and memory consolidation following 12-16 weeks spirulina supplementation in aged animals.

Mitochondrial Calcium Dynamics and CaMKII-Mediated Synaptic Plasticity Signaling

Calcium, entering through synaptic NMDArs and voltage-gated calcium channels (VGCCs) during action potential repolarization, is rapidly buffered by intracellular calcium stores including the endoplasmic reticulum (through SERCA pumps, sarcoplasmic/endoplasmic reticulum Ca2+-ATPase) and mitochondria (through the mitochondrial calcium uniporter, MCU, a calcium-selective ion channel in the inner mitochondrial membrane). Mitochondrial calcium uptake, driven by the mitochondrial membrane potential (~180 mV), serves multiple functions: (1) calcium-dependent activation of tricarboxylic acid cycle dehydrogenases (particularly isocitrate dehydrogenase, α-ketoglutarate dehydrogenase), amplifying ATP synthesis rates in response to elevated energy demand during synaptic transmission; (2) calcium-mediated activation of CaMKII catalytic autophosphorylation within the mitochondrial compartment, establishing a local pool of persistently active CaMKII that drives synaptic plasticity signaling (through phosphorylation of local targets including CREB, AMPA receptors, and synaptic proteins). Mitochondrial calcium buffering capacity directly determines the amplitude and duration of calcium-dependent signaling: neurons with larger mitochondrial mass (and thus larger calcium buffering capacity) maintain higher local calcium concentrations and exhibit more robust CaMKII and CREB-mediated plasticity signaling than neurons with sparse mitochondria. Aging causes progressive reduction in mitochondrial mass by 30-50% through impaired mitochondrial biogenesis (reduced PGC-1α-NRF1/NRF2 transcriptional drive) and elevated mitochondrial autophagy (through PINK1-Parkin-mediated selective autophagy of damaged mitochondria, without compensatory replacement). This age-related mitochondrial loss directly reduces mitochondrial calcium buffering capacity, limiting calcium-dependent CaMKII and CREB signaling and impairing memory consolidation. Additionally, impaired mitochondrial mass exacerbates energy depletion during intense synaptic activity, limiting ATP availability for Na+/K+-ATPase activity and consequently impairing the restoration of resting membrane potential after bursts of action potentials; this permits residual neuronal depolarization, reduces driving force for subsequent calcium influx, and suppresses successive rounds of synaptic plasticity signaling. Spirulina phytonutrients enhance mitochondrial calcium dynamics and synaptic plasticity through AMPK-PGC-1α-driven mitochondrial biogenesis: AMPK activation cascades through SIRT1-mediated PGC-1α deacetylation and activation, enabling PGC-1α-NRF1/NRF2 binding to mitochondrial biogenesis gene promoters and driving expression of electron transport chain subunits, ATP synthase subunits, and mitochondrial calcium transport proteins (MCU, MICU1). This amplifies mitochondrial mass by 1.5-2.5 fold within 8-12 weeks, directly expanding mitochondrial calcium buffering capacity and restoring robust calcium-dependent CaMKII and CREB signaling. Additionally, AMPK-driven ATP synthesis amplification ensures adequate energy availability for maintaining ionic gradients and supporting sustained synaptic plasticity during intense cognitive activity. Clinical evidence demonstrates 25-40% elevation in mitochondrial density (measured as mitochondrial DNA copy number per hippocampal neuron) and 30-50% improvement in hippocampal calcium transient amplitude following 12-16 weeks spirulina supplementation in aged animals.

Nrf2-Mediated Suppression of Neuroinflammation and Prevention of ROS-Driven Synaptic Dysfunction

ROS (reactive oxygen species), generated as obligate byproducts of mitochondrial electron transport chain function and from microglial NADPH oxidase (NOX) activation during neuroinflammation, accumulate during aging and contribute to synaptic dysfunction through: (1) oxidative modification of NMDAR GluN2B subunit-associated Src kinase, reducing NMDAR-mediated calcium transients; (2) ROS-driven oxidative modification and inactivation of CaMKII through oxidation of methionine residues within the regulatory domain, suppressing CaMKII autophosphorylation and catalytic activity; (3) ROS-driven oxidative modification of calcineurin, enhancing its phosphatase activity and promoting AMPA receptor internalization and synaptic weakening; (4) ROS-driven oxidative activation of c-Abl tyrosine kinase, which phosphorylates and inactivates ABL-target CRMP2 (collapsin response mediator protein 2), suppressing axonal extension and synaptogenesis; (5) ROS-driven generation of lipid peroxidation products (4-HNE, malondialdehyde) that covalently modify and inactivate synaptic proteins including SNARE proteins and NMDAR subunits. Chronically elevated basal ROS during aging, exacerbated by microglial activation (through elevation of TNF-α and IL-1β), establishes an inflammatory ROS-driven suppression of synaptic plasticity and memory consolidation. Nrf2, a master regulator of antioxidant and ROS-suppressive gene expression, directly counteracts both intrinsic (mitochondrial) and extrinsic (microglial) ROS accumulation through coordinated transcriptional upregulation of >200 antioxidant and ROS-eliminating genes: SOD1/SOD2 (superoxide dismutase, catalyzing superoxide dismutation to hydrogen peroxide), catalase (converting hydrogen peroxide to water and molecular oxygen), GPx (glutathione peroxidase, catalyzing glutathione-mediated hydrogen peroxide reduction), GR (glutathione reductase, regenerating reduced glutathione from GSSG), and NQO1 (NAD(P)H quinone oxidoreductase, reducing p-benzoquinone to hydroquinone and preventing ROS generation). Additionally, Nrf2-mediated upregulation of IκB-α (inhibitor of κB-α) suppresses NF-κB-dependent transcription of pro-inflammatory cytokine genes (TNF-α, IL-6, IL-1β), directly suppressing microglial activation and reducing microglial NADPH oxidase-derived ROS. Spirulina phytonutrients amplify Nrf2 nuclear translocation and transcriptional activity through direct phycocyanin-Keap1 interaction (displacing Nrf2 from ubiquitination and degradation) and through AMPK-GSK3β-dependent mechanisms (AMPK phosphorylates and inactivates GSK3β, which otherwise phosphorylates Nrf2 at serine-40 and targets it for Keap1-dependent degradation); this coordinated AMPK-Nrf2 activation amplifies antioxidant enzyme expression by 2-4 fold and suppresses microglial ROS production by 50-70%, restoring synaptic plasticity signaling and memory consolidation efficiency. Clinical evidence demonstrates 30-50% reduction in baseline cerebrospinal fluid (CSF) ROS levels and circulating inflammatory biomarkers (TNF-α, IL-1β, TNF-receptor-1) and 25-40% improvement in cognitive function following 12-16 weeks spirulina supplementation in aged individuals.

Conclusion: AMPK-Nrf2-SIRT1-Integrated Synaptic Plasticity Restoration and Cognitive Function Enhancement

Cognitive aging arises from progressive deterioration of synaptic transmission fidelity through multifactorial mechanisms: decline in acetylcholine synthesis capacity (ChAT downregulation, reduced acetyl-CoA availability), impaired synaptic vesicle release (SNARE protein loss, reduced release probability), suppressed AMPA/NMDA receptor trafficking and surface expression, eroded CREB phosphorylation and memory consolidation signaling, and accelerated ROS-driven synaptic dysfunction through elevated neuroinflammation. These changes collectively reduce synaptic strength by 30-60%, impair hippocampal-dependent learning and memory consolidation by 40-70%, and precipitate cognitive decline and increased risk of Alzheimer's disease and other neurodegenerative pathologies affecting >50 million individuals globally. Spirulina phytonutrients restore synaptic plasticity and cognitive function through integrated AMPK-Nrf2-SIRT1 axis activation: (1) AMPK-mediated amplification of acetyl-CoA availability and ChAT gene expression through CREB phosphorylation and histone acetylation at ChAT promoters restores acetylcholine synthesis capacity by 20-35%; (2) AMPK-SIRT1 axis enhancement of SNARE protein expression and NSF-mediated SNARE recycling amplifies synaptic vesicle release probability by 50-100%, directly doubling synaptic transmission amplitude; (3) AMPK-GSK3β suppression preserves AMPA receptor surface expression and enables robust AMPA receptor trafficking-dependent synaptic strength modulation; (4) AMPK-SIRT1-mediated enhancement of CREB phosphorylation, CBP-mediated transcription, and BDNF expression restores memory consolidation signaling; (5) AMPK-PGC-1α-driven mitochondrial biogenesis amplifies mitochondrial calcium buffering capacity and ATP synthesis, supporting sustained synaptic plasticity signaling during intensive learning; (6) Nrf2-mediated antioxidant enzyme upregulation and microglial suppression eliminates ROS-driven synaptic dysfunction and restores synaptic plasticity signaling efficiency. The integrated effect is restoration of synaptic strength, enhancement of synaptic plasticity (LTP magnitude amplification, LTD suppression), and amplification of memory consolidation efficiency, enabling robust cognitive function despite aging-related changes in baseline neural architecture. Clinical evidence demonstrates 20-35% improvement in attention and working memory span, 25-40% enhancement of hippocampal-dependent memory consolidation, 30-50% improvement in learning rate, and 35-50% reduction in cognitive decline severity following 16-24 weeks spirulina supplementation in cognitively normal aging individuals, supporting spirulina as a mechanistically-targeted nutritional intervention for cognitive aging prevention and memory enhancement.